Notably, recombinant human ACE2 (rhACE2) is also widely used in basic and clinical research for converting Ang II to Ang‐(1‐7) against dilated cardiomyopathy in HF patients. The gene discussed is ACE2; the disease is dilated cardiomyopathy.